OncoSil Medical LtdASX: OSL

Appendix 4E - Preliminary final report 30 June 2016

· Issued by OncoSil Medical Ltd

Filed with ASX · · 49 pages · English

Sydney, Australia – 30 August 2016:OncoSil Medical Ltd (ASX: OSL) (Oncosil or theCompany), a late stage medical devices company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to report its financial results for the full year ended 30 June 2016 (the Financial Report) and its Appendix 4E. All financial results are in Australian dollars and are audited. High

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases